Venkatraman, N., Tiono, A. B., Bowyer, G., Bellamy, D. G., Stockdale, L. K., Powlson, J., . . . Hill, A. V. S. (2025). Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: Two phase 1, first-in-human trials. The lancet. Microbe, 6(3), . https://doi.org/10.1016/S2666-5247(24)00084-3
Chicago-Zitierstil (17. Ausg.)Venkatraman, Navin, et al. "Evaluation of a Novel Malaria Anti-sporozoite Vaccine Candidate, R21 in Matrix-M Adjuvant, in the UK and Burkina Faso: Two Phase 1, First-in-human Trials." The Lancet. Microbe 6, no. 3 (2025). https://doi.org/10.1016/S2666-5247(24)00084-3.
MLA-Zitierstil (9. Ausg.)Venkatraman, Navin, et al. "Evaluation of a Novel Malaria Anti-sporozoite Vaccine Candidate, R21 in Matrix-M Adjuvant, in the UK and Burkina Faso: Two Phase 1, First-in-human Trials." The Lancet. Microbe, vol. 6, no. 3, 2025, https://doi.org/10.1016/S2666-5247(24)00084-3.